Orbenin extra dry cow 600 mg suspensie voor intramammair gebruik voor runderen
Orbenin extra dry cow 600 mg suspensie voor intramammair gebruik voor runderen
Authorised
- Cloxacillin hemibenzathine
Product identification
Medicine name:
Orbenin extra dry cow 600 mg suspensie voor intramammair gebruik voor runderen
Active substance:
- Cloxacillin hemibenzathine
Target species:
-
Cattle
Route of administration:
-
Intramammary use
Product details
Active substance and strength:
-
Cloxacillin hemibenzathine600.00/milligram(s)1.00Syringe
Pharmaceutical form:
-
Intramammary suspension
Withdrawal period by route of administration:
-
Intramammary use
-
Cattle
-
Milk44day44 days after last treatment, after calving within 42 days after treatment
-
Milk48hour48 hours after calving after more than 42 days after treatment
-
Meat and offalno withdrawal periodzero days
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QJ51CF02
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Netherlands
Available in:
-
Netherlands
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
- Zoetis B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
- Haupt Pharma Latina S.r.l.
Responsible authority:
- Medicines Evaluation Board
Authorisation number:
- REG NL 6901
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Combined File of all Documents
This document does not exist in this language (English). You can find it
in another language below.
Dutch (PDF)
Published on: 22/05/2024
